COST-EFFECTIVENESS OF VARIOUS COMBINATIONS OF HUMAN PAPILLOMAVIRUS (HPV)-BASED TESTING, INCLUDING GENOTYPING FOR HPV 16/18, FOR CERVICAL CANCER SCREENING

被引：2
|
作者：
Huh, W. [1 ]
Williams, E. [2 ]
Bramley, T. [2 ]
Huang, J. [3 ]
Poulios, N. [3 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] Xcenda, Palm Harbor, FL USA
[3] Roche Mol Diagnost, Pleasanton, CA USA
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.699
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A142 / A143
页数：2
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF VARIOUS COMBINATIONS OF HUMAN PAPILLOMAVIRUS (HPV)-BASED PRIMARY SCREENING TESTING, INCLUDING GENOTYPING FOR HPV 16/18, FOR CERVICAL CANCER SCREENING IN MEXICO
    Corro, A.
    Ramirez, A.
    Williams, E.
    Huang, J.
    Souza, F. H.
    VALUE IN HEALTH, 2013, 16 (07) : A671 - A671
  • [2] Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination
    Goldhaber-Fiebert, Jeremy D.
    Stout, Natasha K.
    Salomon, Joshua A.
    Kuntz, Karen M.
    Goldie, Sue J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (05): : 308 - 320
  • [3] Re: Cost-Effectiveness of Cervical Cancer Screening With Human Papillomavirus DNA Testing and HPV-16,18 Vaccination
    Giorgi Rossi, Paolo
    Zappa, Marco
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (22): : 1654 - 1654
  • [4] Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology
    Agorastos, Theodoros
    Chatzistamatiou, Kimon
    Katsamagkas, Taxiarchis
    Koliopoulos, George
    Daponte, Alexandros
    Constantinidis, Theocharis
    Constantinidis, Theodoros C.
    PLOS ONE, 2015, 10 (03):
  • [5] Cost Effectiveness of Human Papillomavirus-16/18 Genotyping in Cervical Cancer Screening
    Warner K. Huh
    Erin Williams
    Joice Huang
    Tommy Bramley
    Nick Poulios
    Applied Health Economics and Health Policy, 2015, 13 : 95 - 107
  • [6] Cost Effectiveness of Human Papillomavirus-16/18 Genotyping in Cervical Cancer Screening
    Huh, Warner K.
    Williams, Erin
    Huang, Joice
    Bramley, Tommy
    Poulios, Nick
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2015, 13 (01) : 95 - 107
  • [7] COST-EFFECTIVENESS ANALYSIS OF CERVICAL CANCER SCREENING WITH SELF-SAMPLING FOR HUMAN PAPILLOMAVIRUS (HPV) TESTING IN TAIWAN
    Tsai, B. C.
    Chow, I. H. I.
    Liao, C. H.
    You, S. L.
    Tang, C. H.
    Pwu, R. F.
    VALUE IN HEALTH, 2012, 15 (07) : A656 - A657
  • [8] HPV16 and HPV18 genotyping in cervical cancer screening
    Ronco, Guglielmo
    Franceschi, Silvia
    Segnan, Nereo
    LANCET ONCOLOGY, 2011, 12 (09): : 831 - 832
  • [9] Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV study
    Cox, J. Thomas
    Castle, Phillip E.
    Behrens, Catherine M.
    Sharma, Abha
    Wright, Thomas C., Jr.
    Cuzick, Jack
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2013, 208 (03) : 184.e1 - 184.e11
  • [10] Cost-effectiveness analysis of primary human papillomavirus testing in cervical cancer screening: Results from the HPV FOCAL Trial
    Cromwell, Ian
    Smith, Laurie W.
    van der Hoek, Kim
    Hedden, Lindsay
    Coldman, Andrew J.
    Cook, Darrel
    Franco, Eduardo L.
    Krajden, Mel
    Martin, Ruth
    Lee, Marette H.
    Stuart, Gavin
    van Niekerk, Dirk
    Ogilvie, Gina
    Peacock, Stuart
    CANCER MEDICINE, 2021, 10 (09): : 2996 - 3003
12345